Literature DB >> 1378260

Assessing symptom improvement after elective prostatectomy for benign prostatic hypertrophy.

A B Flood1, N A Black, K McPherson, J Smith, G Williams.   

Abstract

BACKGROUND: Elective surgery for benign prostatic hypertrophy requires estimates of likely improvement.
METHODS: Data are from a prospective study of all patients without cancer who underwent transurethral prostatectomy. After eliminating patients for whom surgery was not elective, we examined symptom improvement.
RESULTS: Surgery was effective in reducing symptoms for all but those with very mild preoperative symptoms. For the remainder, the average level of postoperative outcomes achieved was independent of the initial symptom severity.
CONCLUSIONS: Elective prostatectomy is effectiveness for improving symptoms. The improvement is typically sustained, and for some symptoms improvement continues during the first year after surgery. Patients with severe symptoms were as likely to achieve the same level of postoperative improvement as were patients with less severe problems initially. However, patients with very mild symptoms benefited little or none from surgery.

Entities:  

Mesh:

Year:  1992        PMID: 1378260

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

1.  Underdetection of clinical benign prostatic hyperplasia in a general medical practice.

Authors:  M F Collins; R H Friedman; A Ash; R Hall; M A Moskowitz
Journal:  J Gen Intern Med       Date:  1996-09       Impact factor: 5.128

Review 2.  Guidelines, enthusiasms, uncertainty, and the limits to purchasing.

Authors:  M McKee; A Clarke
Journal:  BMJ       Date:  1995-01-14

3.  Urinary symptoms: prevalence and severity in British men aged 55 and over.

Authors:  D J Hunter; C M McKee; N A Black; C F Sanderson
Journal:  J Epidemiol Community Health       Date:  1994-12       Impact factor: 3.710

4.  Change in storage symptoms following laser prostatectomy: comparison between photoselective vaporization of the prostate (PVP) and holmium laser enucleation of the prostate (HoLEP).

Authors:  Min Chul Cho; Seung Beom Ha; Seung-June Oh; Soo Woong Kim; Jae-Seung Paick
Journal:  World J Urol       Date:  2014-11-07       Impact factor: 4.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.